Cavernous Hemangioma - Symptoms & Treatment

Cardiac hemangioma is a infrequent primary benign tumour, localized in the exact atrium in 23% of cases. These benign, vascular lesions are slow growing and can obvious as a painless, increasingly proptotic eye. Most of these tumefactions are extremely unilateral. Bilateral cases have been reported but are infrequent. Orbital cavernous angiomas can enlarge intraorbital volume with an ensuing mass effect. Although cavernous hemangiomas are histologically benign, they can intrude on intraorbital or adjacent structures and can be measured anatomically or positionally malignant. Providentially, these tumors have a life cycle. After rapidly enlarging for a few months, they soothe in size and then slowly begin to shrink of their own accord. Eventual complete or almost complete evaporation of these masses is the rule.

Hemangiomas should be incredibly soft and squishy to feel. They are blood vessel tumors, and are intrinsically soft. The morbidity related with cavernous hemangiomas is the risk of compressive optic neuropathy, extra ocular muscle dysfunction, and cosmetic mutilation. Mortality can consequence from intraoperative complications, such as bleeding and the risk of common anesthesia. While most often related with the skin, it is also occasionally initiate in mucous membranes, the brain, and the viscera. In all cases, it is present fully residential at birth; it is seldom malignant and increases in size only to the same extent as that of the body part involved. There is no suitable treatment. For cosmetic intention, surgery, if feasible, may be measured. The tumors frequently arise in middle-aged women.

Causes of Cavernous Hemangioma

Some causes & risk factors of Cavernous Hemangioma are as follows:

• The reason of hemangiomas is unidentified.
• Hemangiomas most commonly arise in females and in impulsive infants.
• Patients generally manifest symptomatically for the period of the third to fifth decades of life.

Symptoms of Cavernous Hemangioma

Some sign and symptoms related to Cavernous Hemangioma are as follows:

• Bleeding or hamper with organ task.
• In uncommon cases, a cavernous hemangioma may rupture.
• Inflamed liver.

Treatment of Cavernous Hemangioma

• There are three main treatment preferences for cavernous malformations observation, surgery and stereotactic radiosurgery.
• Surgery is the most widespread treatment option when treatment is required.
• Most patients (just about 60-80%) promote from sclerotherapy.
• Radiofrequency ablation for dealing of symptomatic low-flow vascular malformations. Radiofrequency ablation is usually intended for cancers of the liver, kidneys, lung and bone.
• Use of the carbon dioxide laser or yag laser is a different modality for the surgeon faced with the task of tumor elimination.